CON

CON

USD

Concentra Group Holdings Parent Inc. Common Stock

$21.780+0.080 (0.369%)

Reaalajas hind

Healthcare
Medical Care Facilities
Ameerika Ühendriigid

Hinnagraafik

Loading Chart...

Põhinäitajad

Turunäitajad
Ettevõtte fundamentaalnäitajad
Kauplemisstatistika

Turunäitajad

Avatud

$21.700

Kõrge

$21.980

Madal

$21.395

Maht

0.06M

Ettevõtte fundamentaalnäitajad

Turukapitalisatsioon

2.8B

Tööstusharu

Medical Care Facilities

Riik

United States

Kauplemisstatistika

Keskmine maht

0.79M

Börs

NYQ

Valuuta

USD

52 nädala vahemik

Madal $18.89Praegune $21.780Kõrge $24.805

Tehisintellekti analüüsiaruanne

Viimati uuendatud: 2. mai 2025
Tehisintellekti loodudAndmeallikas: Yahoo Finance, Bloomberg, SEC

CON (Concentra Group Holdings Parent Inc. Common Stock): Analyzing Recent Moves & What Might Come Next

Stock Symbol: CON Generate Date: 2025-05-02 16:21:32

Alright, let's break down what's been happening with Concentra stock lately and what the tea leaves might be suggesting. We'll look at the recent news, how the price has been acting, and what some automated predictions are saying.

Recent News Buzz

So, what's the latest chatter around Concentra? There are a few key things that popped up recently:

  1. Earnings Coming Up: The big news is that Concentra plans to announce their first-quarter results for 2025 on May 7th, right after the market closes. This is a pretty standard announcement, but it's a major event for any stock. Investors will be watching closely to see how the company performed financially. It's a moment of anticipation – results could be good, bad, or somewhere in between, and that will definitely move the stock price.
  2. Analyst Thumbs Up: Back in March, a JP Morgan analyst named Lisa Gill gave Concentra a positive rating ("Overweight") and even nudged her price target up a dollar, from $29 to $30. This is generally seen as a good sign. When a respected analyst thinks a stock is worth more than they previously did, it can give other investors confidence.
  3. Expanding the Footprint: Also in March, Concentra announced they opened a new medical center in Waukegan, Illinois. Since Concentra is all about occupational medicine (helping people with work-related health stuff), opening new locations means they're growing their business. That's usually a positive development for a company's long-term prospects.

Putting the news together, the vibe is somewhat mixed but leans positive overall. You've got solid business growth news (expansion) and a vote of confidence from an analyst (price target raise). The upcoming earnings report is the big unknown, creating a bit of a wait-and-see situation.

Price Check: What the Chart Shows

Looking at the stock's price over the last 30 days or so, it's been a bit of a rollercoaster. Back in early March, the price was hanging around the $22-$23 mark. Then, it took a noticeable dip, falling below $21 by mid-March and even touching the $19 range briefly in early April.

However, since that dip in early April, the stock has shown signs of bouncing back. It's been gradually climbing, moving from the $19-$20 area back up towards the $21-$22 range in the latter half of April and into early May. The last recorded price point shows it around $21.61.

Comparing the current price to the recent trend, it seems to be recovering from that earlier dip and is now sitting near the upper end of its range over the last few weeks, though still below where it was in early March.

What about the AI's crystal ball? The prediction model suggests minimal movement today (0.00%), a small bump tomorrow (+0.56%), and then a more significant jump the day after (+3.63%). This forecast points towards a potential upward move in the very near term.

Outlook & Ideas: What Might This Mean?

Based on the news, the recent price action, and the AI's short-term prediction, the situation for CON looks cautiously optimistic in the immediate future, but with a big asterisk for the upcoming earnings report.

  • The Lean: The combination of positive news (expansion, analyst upgrade), a recent price recovery, and an AI predicting upward movement suggests the near-term leaning might favor those looking to potentially buy or hold. It doesn't scream "sell" right now, but the earnings report is a major wildcard that could change things fast.
  • Potential Entry Consideration: If you were considering getting into this stock, the current price area, around $21.50-$21.60, might be a point to look at. The AI prediction data even flagged entry points around $21.54 and $21.64. This level seems to be acting as a recent point of interest after the stock's recovery. However, remember the earnings report is just days away, which adds risk.
  • Potential Exit/Stop-Loss Consideration: If you're already in or decide to get in, thinking about where you might take profits or cut losses is smart. The AI data suggested a potential take-profit level around $21.96. This is close to recent highs and aligns with the idea of a short-term upward move. For managing risk, a potential stop-loss level mentioned in the data is $19.38. Placing a stop-loss below recent significant lows (like that dip in early April) is a common strategy to limit potential losses if the stock turns south unexpectedly, especially after the earnings announcement.

Company Context

Just a quick reminder about Concentra: they are a healthcare company focused on occupational medicine. This means their business is tied to employers needing health services for their workers (like injury care, physicals, drug testing). So, news about expanding locations or trends in the job market and workplace safety are particularly relevant to how this company performs. They are a sizable company with over 8,700 employees and a market cap around $2.77 billion.

Remember, this analysis is based only on the data provided and is just one perspective. Stock markets can be unpredictable, and prices can go down as well as up.


Disclaimer: This report is for informational and analytical purposes only and should not be considered financial advice. It is based on the provided data and interpretations thereof. Investing in stocks involves risk, and you could lose money. Always conduct your own thorough research or consult with a qualified financial advisor before making any investment decisions.

Seotud uudised

BusinessWire

Concentra® to Announce First Quarter 2025 Results on Wednesday, May 7, 2025

Concentra® Group Holdings Parent, Inc. ("Concentra") (NYSE:CON) will release the financial results for its first quarter ended March 31, 2025, on Wednesday, May 7, 2025, after the market closes. Concentra will

Vaata rohkem
Concentra® to Announce First Quarter 2025 Results on Wednesday, May 7, 2025
Analyst Upgrades

JP Morgan Maintains Overweight on Concentra Group Holdings, Raises Price Target to $30

JP Morgan analyst Lisa Gill maintains Concentra Group Holdings with a Overweight and raises the price target from $29 to $30.

Vaata rohkem
JP Morgan Maintains Overweight on Concentra Group Holdings, Raises Price Target to $30
BusinessWire

Concentra Expands to Waukegan, Illinois

Concentra®, the nation's leader in occupational medicine, today announced the opening of a new medical center in Waukegan, Illinois. The medical center, Concentra Waukegan, is conveniently located at 3043A

Vaata rohkem
Concentra Expands to Waukegan, Illinois

Tehisintellekti ennustusBeta

Tehisintellekti soovitus

Tõusev

Uuendatud kell: 3. mai 2025, 16:28

LangevNeutraalneTõusev

64.7% Kindlus

Risk ja kauplemine

Riskitase3/5
Keskmine risk
Sobib
Väärtus
Kauplemisjuhend

Sisenemispunkt

$21.69

Võta kasum

$22.18

Peata kahjum

$19.57

Põhitegurid

PDI 6.1 on MDI 6.0 kohal ADX-iga 10.3, mis viitab tõusutrendile
Praegune hind on tugitasemele ($21.73) äärmiselt lähedal, mis viitab tugevale ostuvõimalusele
Kauplemismaht on 5.5x keskmisest (7,075), mis viitab äärmiselt tugevale ostusurvele
MACD 0.0170 on signaalijoone 0.0192 all, mis viitab langevale ristumisele

Püsi kursis

Määrake hinnateavitused, hankige tehisintellekti analüüsi uuendusi ja reaalajas turuuudiseid.